Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention
Yesehak Abraham, Social Media Manger at Sheromeda Gebya, Sales and Marketing Officer at Ze-el Pharmaceutical Import, shared a post on LinkedIn:
“Enoxaparin: The Quiet Hero in Blood Clot Prevention
Most people never think about blood clots… until they become a problem.
That’s where Enoxaparin steps in a small injection with a big clinical impact.
What it does :
It helps prevent dangerous clots by slowing down specific clotting factors (especially Factor Xa), keeping blood flow smooth and safe.
Where it’s commonly used:
- Post – surgery patients
- Bedridden or immobile patients
- Acute coronary syndromes
- DVT/PE prevention and treatment
Clinical reality:
Predictable. Effective. No routine monitoring in most cases.
But always respect renal function and bleeding risk.
‘Enoxaparin doesn’t dissolve clots… it just politely stops them from forming group chats in your bloodstream.’
Patient reminder:
- Small bruises can be normal
- Don’t massage injection sites
- Report unusual bleeding immediately
Final thought:
Sometimes the most powerful treatments are not dramatic – just precise, consistent, and quietly life – saving.”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 16:17W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
-
Apr 29, 2026, 16:12Mavis Agnes Kisakye: Concluding a Successful Entrepreneurship Training for Our Mothers
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share on Our Chapter Being Published in Medicine Update 2026
-
Apr 29, 2026, 15:46Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
-
Apr 29, 2026, 15:44Sonal Sonu: Securing First Prize in Research Oral Presentation at the CME
-
Apr 29, 2026, 15:43Andrew Shaw: Long COVID First Diagnostic Classification with 69% accuracy
-
Apr 29, 2026, 15:41Yazan Abou-Ismail: Contributing Evidence-Based Topic Review on the Evaluation of Easy Bruising
-
Apr 29, 2026, 15:36Mohamed Sherif Salem: Expanding the Role of Tenecteplase in Acute Ischemic Stroke
-
Apr 29, 2026, 15:31WFH Humanitarian Aid Program Reflects on a Result of Years of Consistent Work with AHTA – Yeolyan Hematology and Oncology Center